Govts urged to support homegrown tech
02 April, 2003 by Iain ScottStart-ups are hard work and technology-based start-ups even harder, the CEO of one of Australia's best-known such ventures told last week's KCA commercialisation conference.
Research strengths key to good tech transfer: Penn head
01 April, 2003 by Iain ScottEminent scientists should remain in the lab producing research results, rather than join a start-up company based on their work, according to the head of one of the most successful technology transfer offices in the US.
BigShop loses bid for Biota board
28 March, 2003 by Melissa TrudingerA bid by Perth entrepreneur Farooq Khan to win a seat on the board of Biota Holdings was defeated by other shareholders at a heated meeting in Melbourne this afternoon.
Tapping biotech's human resources
27 March, 2003 by Pete YoungAlthough Australia has some great researchers coming out of its universities, attracting and keeping scientists and biostatisticians local can be a problem, Pete Young finds.
The value of good researchers
26 March, 2003 by Melissa TrudingerNobel Laureate Prof Peter Doherty is lending his name to a new prize to be awarded at Australia's first Commercialisation Forum and Fair of Ideas, which started in Sydney today and runs to March 28.
Biotech by degrees
25 March, 2003 by Melissa TrudingerUndergraduate level biotechnology degree programs are becoming increasingly popular in Australia, offering students the opportunity to combine the essential basic science requirements with exposure to business and other aspects of the industry.
Bid to oust VRI Biomedical board
21 March, 2003 by Iain ScottOne of Perth-based probiotics company VRI Biomedical's largest shareholders has launched a bid to remove most of the company's board and move key management to Sydney.
Hearts and minds the stakes as Biota-BigShop clash looms
20 March, 2003 by Pete YoungA battle for the hearts and minds of Biota Holdings shareholders is intensifying on the eve of a confrontation between the board of the embattled biotech and its largest stakeholder.
Aussie biotechs should jump on soft US market: Nasdaq VP
18 March, 2003 by Melissa TrudingerThe soft IPO market in the US could be advantageous to Australian biotech companies seeking to raise their profile in the US, Nasdaq Asia-Pacific VP Patrick Sutch told an audience of biotech CEOs in Melbourne today.
US experience snapped up by locals
18 March, 2003 by Jeremy TorrIn a flurry of recent announcements, ex-Pfizer scientific director Kevin Fahey has been appointed to the boards of three local set-ups.
Confronting the big picture
13 March, 2003 by Melissa TrudingerAccording to Bob Horvitz, along with Sydney Brenner and John Sulston one of the winners of the 2002 Nobel Prize in Physiology and Medicine, there are four big-picture problems confronting biologists today.
The lowdown on high-profile science
13 March, 2003 by Melissa TrudingerFrom institutes with fewer than 100 staff to the CSIRO with several thousand, the vast majority of Australia's life scientists are employed by research institutes. Among the dozens of research institutes found across the country are numerous internationally renowned centres of scientific excellence like the Walter and Eliza Hall Institute of Medical Research (WEHI), small focused institutes like Melbourne's Bionic Ear Institute and government-owned agricultural institutes like the South Australian Research and Development Institute (SARDI).
Going the extra yard
12 March, 2003 by Melissa HulbertProf Peter Rowe, the current Lorimer Dods Professor and Director of the Children's Medical Research Institute (CMRI), Westmead, NSW, is gearing up for his final few years in this position.
Carr pledges millions to health research in election promises
12 March, 2003 by Jeremy TorrIf Labor is re-elected to office in NSW on March 22 it will create a new State Minister for Science and Medical Research, and would also set up a new cancer institute, Premier Bob Carr has announced.
Dollars, cents and science
11 March, 2003 by Graeme O'NeillWith apologies to Kermit, TV's most famous amphibian, it's sometimes easier being green. In the perennial quest for funding, those Australian research institutes with ivy on their walls are doing best.
